2012 lecture

2012 lecture

by Academy Admin

The 2012 lecture was delivered by Professor Carole Goble, School of Computer Science, University of Manchester.

'Work with Scientists: Fun, Profit & the e in e-Science'

Presentation slides

About the speaker

Carole Goble is a career academic based in the School of Computer Science, University of Manchester since she attended as an undergraduate in 1979.

She co-leads the Information Management Group (IMG) and directs the myGrid project, a large mixed team of researchers, computational scientists and software engineers that specialises in e-Science research and builds widely adopted, open source software and fielded services. Her interest is in the acceleration of scientific innovation through automation, knowledge management and social interaction.

Her research interests lie in ontologies, knowledge / semantic technologies, social computing, the web and scientific workflow systems applied to information management problems in scientific / research disciplines, notably the Life Sciences. The myGrid team is responsible for the widely used Taverna workflow system; the myExperiment, MethodBox and SEEK virtual research environments for scientists; and practical semantic tools such as RightField.

Carole is a partner in the UK’s Open Middleware Infrastructure Institute and the Software Sustainability Institute. She currently leads the technical development of a European BioDiversity Virtual e-Laboratory, the Concept Services for the OpenPHACTS public-private partnership to build a Semantic Web for European Drug Discovery, and the long-term preservation of scientific workflows (Wf4Ever).

In 2008 Carole was awarded the inaugural Microsoft Jim Gray award for outstanding contributions to e-Science. In 2010 she was elected a Fellow of the Royal Academy of Engineering for her contributions to e-Science, and she chaired the UK Research Councils review of e-Infrastructure for Science and Innovation. In 2012 she was nominated for the Benjamin Franklin award for Open Access in the Life Sciences.